Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos
about
Asbestos, Asbestosis, Smoking, and Lung Cancer. New Findings from the North American Insulator CohortNanoparticles, lung injury, and the role of oxidant stressNew perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsPulmonary toxicity, distribution, and clearance of intratracheally instilled silicon nanowires in ratsMeeting report: mode(s) of action of asbestos and related mineral fibersThe Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary FibrosisNew insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomasOxidative stress and pulmonary fibrosisEvaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humansThe NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseasesAmphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 miceAsbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsNon-neoplastic and neoplastic pleural endpoints following fiber exposureQuantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity.Lung carcinogenicity of inhaled multi-walled carbon nanotube in ratsIndications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cellsUse of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitroAsbestos-Induced Gastrointestinal Cancer: An UpdateQuantitative analysis of the role of fiber length on phagocytosis and inflammatory response by alveolar macrophagesBiological and environmental interactions of emerging two-dimensional nanomaterials.Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomasThe risk of lung cancer after cessation of asbestos exposure in construction workers using pleural malignant mesothelioma as a marker of exposure.Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.Asbestos-induced pulmonary fibrosis is augmented in 8-oxoguanine DNA glycosylase knockout mice.Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice.Molecular basis of asbestos-induced lung disease.Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response.Potential health hazards associated with exposures to asbestos-containing drywall accessory products: A state-of-the-science assessment.Evaluation of tremolite asbestos exposures associated with the use of commercial products.Heme oxygenase-1 in environmental toxin-induced lung disease.Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs).The role of genotoxicity in asbestos-induced mesothelioma: an explanation for the differences in carcinogenic potential among fiber types.Toxicogenetic profile and cancer risk in Lebanese.Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use.Toxicological and epidemiological studies on effects of airborne fibers: coherence and public [corrected] health implications.First Identification of Pulmonary Asbestos Fibres in a Spanish Population.SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.The role of Rho-kinases in IL-1β release through phagocytosis of fibrous particles in human monocytes.
P2860
Q22306305-C1436F54-EAC2-4FE7-A5DD-EEDE605FA106Q23909830-8B678653-02FB-4AC2-B6FC-B59F7FD8FB16Q23910479-6E8BAFAF-F92B-4605-B4D0-4E393D9F3762Q23914730-DC36A003-A14A-4366-A3D1-55025CA5377AQ23918083-619CD01D-2AD2-4D5F-AA4E-B9C53AE38AFFQ26786969-0F7981F7-D717-4742-BA15-49C7BED6FEEDQ26859274-72E78237-F076-4A0A-A40A-8B23F016B23AQ27024861-BCCF6A5D-3447-4FC3-A147-33B245956CACQ27908506-1F394358-0EF1-4958-92F5-62BF0D25EDE4Q28080249-8FE2235F-1A6C-4C78-A43C-28F87D16485EQ28387415-00365430-99BC-4598-B287-F3B36BE8BF35Q28387699-4253C904-8EB0-421B-9006-D20D2D83A125Q28389555-B5BC66DC-9E36-41D5-BF39-329693EA2754Q28391098-19895E1C-D7B6-4EA4-9662-25F63C774757Q28391639-C5589842-18F4-4ED3-A287-AE06C2C0BE38Q28392117-3A471934-D397-4387-B3F5-A3E4F89D382DQ28393135-AD397EAB-6993-440D-9318-60225320F25BQ28393737-16FE7C70-7ADC-4FBE-8160-8CD711D14E71Q28397989-CB9C2986-6FB1-4051-8F48-B390EDEA18C4Q30736816-CC7F6854-44B0-4944-AD34-C99110297B33Q34097257-07F5A9A2-844A-40D1-A0C4-C094F7498658Q34471229-0F3A548B-2703-40D1-81EA-2F54CDCCD02DQ34570415-9F06EBD0-BAB1-4A5A-89DD-045B2AF28629Q34692085-47C78380-C4E3-4284-A94E-FD5542B04555Q35207693-223C97B8-CFB5-4396-91CD-EDC60FB6DF61Q36557014-E97544D2-5CCA-45FE-A1E3-56C1C9F4CDD0Q37509253-35FBA513-FB65-49C5-B2F3-9EB13ED6EA28Q37596494-12084B8B-6646-4FA2-B0F0-55474A0F3693Q37951552-F922C9F3-7957-4EE4-9556-C8260F010BADQ37964699-66657DEF-6569-417C-AFC4-DA150DCC00BCQ37991018-03F1DEA5-4B18-43C5-A969-5621F6958787Q38122211-62AC5FF6-D592-44E8-BE5A-3A1F21CFAD96Q38125794-C8C04C27-68A3-4083-BA5A-3B76039B97FAQ38195853-1E64E6E2-C595-4D49-853F-23C8FED2CFFEQ38223001-2844D5B6-2E2C-43A5-A425-697C031AB000Q38244270-A33C25CA-FDC1-43DD-9AB7-0C0543A294BBQ38632846-BF6180C1-141D-4D18-ACAF-8C0583F31645Q38930521-F80E322A-7847-4D2E-81D5-757824F98072Q38972707-B555F6CE-B77B-41B9-A632-5A4277BFD78FQ39001616-44772DFA-2713-4332-A30C-923C53418D6C
P2860
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@ast
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@en
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@nl
type
label
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@ast
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@en
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@nl
prefLabel
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@ast
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@en
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@nl
P2093
P2860
P921
P3181
P1476
Pulmonary endpoints (lung carc ...... nhalation exposure to asbestos
@en
P2093
Brooke T Mossman
James C Bonner
Karl T Kelsey
Morton Lippmann
Thomas W Hesterberg
P2860
P304
P3181
P356
10.1080/10937404.2011.556047
P407
P5008
P577
2011-01-01T00:00:00Z